Vertex Pharmaceuticals, Inc. (VRTX)
434.30
-4.41
(-1.01%)
USD |
NASDAQ |
Apr 06, 16:00
434.30
0.00 (0.00%)
After-Hours: 20:00
Vertex Pharmaceuticals SG&A Expense (TTM) : 1.753B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| Amgen, Inc. | 7.05B |
| Moderna, Inc. | 1.018B |
| Eli Lilly & Co. | 11.09B |
| Regeneron Pharmaceuticals, Inc. | 2.70B |